“DOSE REDUCTION OF THE ANTICANCER DRUG CISPLATIN MODULATED BY THYMOQUINONE AGAINST LIVER CANCER CELLS (HEPG2) THROUGH APOPTOSIS AND CELL CYCLE ARREST ”